Ligand validation:7NUI

EDO: 1,2-ETHANEDIOL

EDO is a Ligand Of Interest in 7NUI designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7NUI_EDO_A_502	57%	68%	0.196	0.974	0.42	0.79	-	-	0	0	100%	1
7NUI_EDO_A_503	28%	90%	0.137	0.788	0.56	0.07	-	-	0	0	100%	1
7NUI_EDO_A_501	24%	83%	0.22	0.85	0.45	0.33	-	-	0	0	100%	1
7NUI_EDO_A_504	20%	77%	0.189	0.788	0.48	0.44	-	-	0	0	100%	1
4U1M_EDO_A_302	86%	82%	0.09	0.96	0.53	0.27	-	-	0	0	100%	1
4U1L_EDO_A_303	81%	83%	0.124	0.977	0.28	0.5	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.